One of the reasons biotech stocks can be your portfolio’s biggest winners is because of the massive profits companies see after releasing a...
Usually the best stocks to buy have not already tripled in value within the past six months.
But then there's Intercept Pharmaceuticals...
In bioscience investing, binary catalysts are milestone events that signal a thumbs-up or thumbs- down for an...
The FDA's Expedited Programs help get promising new therapies for seriously ill patients approved as soon as ...
Shares of Tesaro Inc. (Nasdaq: TSRO) stock were up 23% today (Monday) after the company announced that its drug rolapitant met...
Our roundup of the best stocks to buy last week gave Money Morning Members more than a dozen plays in 2014's most...
One strategy experts use when looking for the best biotech stocks to buy is finding companies with promising drug candidates that are close to...
When Valeant Pharmaceuticals International Inc. (NYSE: VRX) and activist investor Bill Ackman made an unsolicited $46 billion...
Investors looking for stocks to buy in 2014 have had an abundance of new options as 94 companies have gone public this year, according to...
There's no sugarcoating it: Biotech stocks have had a rough run in the past month.
But when other investors are running for the...
Some analysts feel that the biotech sector's recent tumble is evidence of the biotech bubble bursting.
In the pharmaceutical industry, a "blockbuster" is any drug that brings in $1 billion or more in revenue per year.
It's the prize that...
As a long-time tech-investing analyst, I have one of the best vantage points in the country for tracking profitable marijuana industry...
To be worth an investor's money, any promising pre-profit biotech needs to offer high scores on three fundamental benchmarks: pipeline depth,...
Early last year, I saw a research study that said nearly 60% of all U.S. workers have a net worth of less than $25,000.
And that means...
You can make huge gains investing in a breakthrough drug, but you can do even better putting your money into a new, cutting-edge technology...
The recent spate of uninspiring data, from unemployment to retail sales, has been blamed on the unrelenting cold and snowy winter. But one group...
When you're evaluating a biotech, or even a full-fledged pharmaceutical company, you'll want to look at its product pipeline, upcoming catalysts,...
Biotech stocks have delivered a healthy dose of returns to investors...
More pharmaceutical companies will lose drug patents to the patent cliff in 2014, threatening billions of dollars in revenue for Big Pharma....
